Allan Jensen serves as the Vice President and Chief Procurement Officer at ALK, where he leverages over 15 years of leadership experience to optimize and manage supply operations across multiple sites in the US and Europe. In his current role, Allan is pivotal in shaping...
Allan Jensen serves as the Vice President and Chief Procurement Officer at ALK, where he leverages over 15 years of leadership experience to optimize and manage supply operations across multiple sites in the US and Europe. In his current role, Allan is pivotal in shaping the strategic procurement strategy, focusing on transformation and execution that drives value across direct, indirect, and capital expenditure procurement. His expertise spans strategic sourcing and procurement, supply chain management, and contract manufacturing, making him a key player in enhancing ALK’s operational efficiency and competitiveness in the pharmaceutical industry.
Allan is deeply committed to building a performance culture that fosters engagement and innovation within his teams. He excels in process optimization and change management, ensuring that ALK adapts to the ever-evolving market demands while maintaining compliance with FDA regulations and quality standards. His strategic vision is complemented by a hands-on approach to execution, enabling him to implement effective supply chain operations that enhance productivity and reduce costs.
Key projects under Allan's leadership include the development of a comprehensive sourcing strategy that aligns with ALK's global product supply and commercial operations. By harnessing lean manufacturing principles and implementing robust standard operating procedures (SOPs), he has successfully driven significant improvements in operational performance. Allan's ability to navigate complex supply chain dynamics and foster collaborative relationships with stakeholders positions him as a transformative leader in the pharmaceutical sector, dedicated to advancing ALK’s mission of delivering high-quality allergen immunotherapy products to patients worldwide.
